JN Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 85: 2490-2497, 2001;
0022-3077/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tozzi, A.
Right arrow Articles by Mercuri, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tozzi, A.
Right arrow Articles by Mercuri, N. B.

The Journal of Neurophysiology Vol. 85 No. 6 June 2001, pp. 2490-2497
Copyright ©2001 by the American Physiological Society

Group I mGluRs Coupled to G Proteins Are Regulated by Tyrosine Kinase in Dopamine Neurons of the Rat Midbrain

Alessandro Tozzi,1 Ezia Guatteo,1 Luigi Caputi,2 Giorgio Bernardi,1,2 and Nicola B. Mercuri1,2

 1Istituto di Ricovero e Cura a Carattere Scientifico Fondazione S. Lucia, 00179 Rome; and  2Clinica Neurologica, Università di Tor Vergata, 00133 Rome, Italy

Tozzi, Alessandro, Ezia Guatteo, Luigi Caputi, Giorgio Bernardi, and Nicola B. Mercuri. Group I mGluRs Coupled to G Proteins Are Regulated by Tyrosine Kinase in Dopamine Neurons of the Rat Midbrain. J. Neurophysiol. 85: 2490-2497, 2001. Metabotropic glutamate receptors (mGluRs) modulate neuronal function via different transduction mechanisms that are either dependent or independent on G-protein function. Here we investigated, using whole cell patch-clamp recordings in combination with fluorimetric measurements of intracellular calcium concentration ([Ca2+]i), the metabolic pathways involved in the responses induced by group I mGluRs in dopamine neurons of the rat midbrain. The inward current and the [Ca2+]i increase caused by the group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG, 100 µM) were permanently activated and subsequently abolished in cells loaded with the nonhydrolizable GTP-analogue GTP-gamma -S (600 µM). In addition, when GDP-beta -S (600 µM) was dialyzed into the cells to produce the blockade of the G proteins, the DHPG-dependent responses were reduced. When the tissue was bathed with the phospholipase C inhibitor 1-[6[[(17beta )-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]exyl]-1H-pyrrole-2,5-dione (10 µM), the DHPG-induced calcium transients slightly diminished but the associated inward currents were not affected. Interestingly, a substantial depression of the DHPG-induced inward current and transient increase of [Ca2+]i was caused by the protein tyrosine kinase inhibitors tyrphostin B52 (40 µM) and 4',5,7-trihydroxyisoflavone (genistein; 40 µM), whereas genistein's inactive analogue 4',5,7-trihydroxyisoflavone-7-glucoside (40 µM) was ineffective. The blockade of the Src family of tyrosine kinase by 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (20 µM), mitogen-activated protein kinase by 2'-amino-3' methoxyflavone (50 µM), and protein kinase C by staurosporine (1 µM) had no effect on the cellular responses caused by DHPG. The mGluR5-selective antagonist 2-methyl-6-(phenylethynyl)-pyridine (10-100 µM) did not affect the actions of DHPG. Thus our results indicate that the responses, mainly mediated by mGluRs1 in dopamine neurons, are activated by intracellular mechanisms coupled to G proteins and regulated by tyrosine kinases.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
F. Ferraguti, L. Crepaldi, and F. Nicoletti
Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives
Pharmacol. Rev., December 1, 2008; 60(4): 536 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Satow, S. Maehara, S. Ise, H. Hikichi, M. Fukushima, G. Suzuki, T. Kimura, T. Tanaka, S. Ito, H. Kawamoto, et al.
Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed Investigations with a Selective Allosteric Metabotropic Glutamate Receptor 1 Antagonist, FTIDC [4-[1-(2-Fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 577 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. Kettunen, D. Hess, and A. E. Manira
mGluR1, But Not mGluR5, Mediates Depolarization of Spinal Cord Neurons by Blocking a Leak Current
J Neurophysiol, October 1, 2003; 90(4): 2341 - 2348.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. C. Lee, R. K. S. Wong, S.-C. Chuang, H.-S. Shin, and R. Bianchi
Role of Synaptic Metabotropic Glutamate Receptors in Epileptiform Discharges in Hippocampal Slices
J Neurophysiol, October 1, 2002; 88(4): 1625 - 1633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online